Concorde Asset Management LLC Acquires New Position in Medical Properties Trust, Inc. $MPT

Concorde Asset Management LLC purchased a new position in shares of Medical Properties Trust, Inc. (NYSE:MPT) during the second quarter, Holdings Channel.com reports. The fund purchased 158,210 shares of the company’s stock, valued at approximately $745,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Amundi grew its stake in Medical Properties Trust by 1.6% during the 2nd quarter. Amundi now owns 388,683 shares of the company’s stock worth $1,796,000 after buying an additional 6,252 shares during the last quarter. Continuum Advisory LLC bought a new stake in Medical Properties Trust in the second quarter valued at $31,000. Nykredit A S bought a new stake in Medical Properties Trust in the second quarter valued at $41,000. OneAscent Family Office LLC acquired a new position in shares of Medical Properties Trust during the second quarter valued at $49,000. Finally, Greenspring Advisors LLC acquired a new position in shares of Medical Properties Trust during the second quarter valued at $54,000. Institutional investors and hedge funds own 71.79% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on MPT. Wells Fargo & Company dropped their price objective on shares of Medical Properties Trust from $5.00 to $3.80 and set an “underweight” rating on the stock in a report on Tuesday, September 1st. Weiss Ratings lowered shares of Medical Properties Trust from a “sell (d+)” rating to a “sell (d)” rating in a research note on Tuesday, August 18th. Finally, Royal Bank Of Canada dropped their price target on shares of Medical Properties Trust from $5.00 to $4.50 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th. One investment analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Sell” and an average price target of $4.15.

Medical Properties Trust Price Performance

Shares of MPT opened at $4.00 on Wednesday. The company has a debt-to-equity ratio of 2.16, a current ratio of 3.12 and a quick ratio of 3.12. The stock has a 50 day simple moving average of $4.41. Medical Properties Trust, Inc. has a 12-month low of $3.89 and a 12-month high of $6.47. The firm has a market cap of $2.39 billion, a PE ratio of -66.67 and a beta of 1.40.

Medical Properties Trust (NYSE:MPT) last released its earnings results on Monday, August 10th. The company reported $0.15 EPS for the quarter, meeting the consensus estimate of $0.15. The business had revenue of $259.28 million during the quarter. Medical Properties Trust had a negative net margin of 2.96% and a negative return on equity of 0.66%. Medical Properties Trust’s revenue was up 7.9% compared to the same quarter last year. As a group, equities research analysts forecast that Medical Properties Trust, Inc. will post 0.6 EPS for the current fiscal year.

Medical Properties Trust Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 8th. Shareholders of record on Thursday, September 10th will be issued a $0.09 dividend. The ex-dividend date of this dividend is Thursday, September 10th. This represents a $0.36 annualized dividend and a dividend yield of 9.0%. Medical Properties Trust’s dividend payout ratio is currently -600.00%.

Medical Properties Trust Profile

Medical Properties Trust, Inc (NYSE: MPT) is a real estate investment trust (REIT) that acquires, owns and finances hospitals and other healthcare facilities. Founded in 2003 by Edward K. Aldag Jr., the company’s business model centers on providing real estate capital to healthcare operators through long-term leases, sale-leaseback transactions, build-to-suit developments and mortgage financing. By specializing in healthcare real estate, MPT aims to deliver steady rental income and asset-based returns while enabling operators to access capital for clinical operations and growth.

The company’s portfolio primarily comprises acute care hospitals, inpatient rehabilitation hospitals, long-term acute care facilities, behavioral health centers and other specialty hospitals.